Search Results - "Mantua, V."

Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 by Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., Kivipelto, M.

“…The modern era of drug development for Alzheimer's disease began with the proposal of the cholinergic hypothesis of memory impairment and the 1984 research…”
Get full text

Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology by Ferretti, M T, Martinkova, J, Biskup, E, Benke, T, Gialdini, G, Nedelska, Z, Rauen, K, Mantua, V, Religa, D, Hort, J, Santuccione Chadha, A, Schmidt, R

“…Alzheimer's disease (AD) is characterized by high heterogeneity in disease manifestation, progression and risk factors. High phenotypic variability is…”
Get full text

Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group by Robert, P., Lanctôt, K.L., Agüera-Ortiz, L., Aalten, P., Bremond, F., Defrancesco, M., Hanon, C., David, R., Dubois, B., Dujardin, K., Husain, M., König, A., Levy, R., Mantua, V., Meulien, D., Miller, D., Moebius, H.J., Rasmussen, J., Robert, G., Ruthirakuhan, M., Stella, F., Yesavage, J., Zeghari, R., Manera, V.

“…Apathy is a very common behavioural and psychological symptom across brain disorders. In the last decade, there have been considerable advances in research on…”
Get full text

Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice by Ferretti, M. T., Martinkova, J., Biskup, E., Benke, T., Gialdini, G., Nedelska, Z., Rauen, K., Mantua, V., Religa, D., Hort, J., Santuccione Chadha, A., Schmidt, R.

“…Alzheimer’s disease (AD) is characterized by high heterogeneity in disease manifestation, progression and risk factors. High phenotypic variability is…”
Get full text

Does psychomotor retardation define a clinically relevant phenotype of unipolar depression? by Calugi, S, Cassano, G.B, Litta, A, Rucci, P, Benvenuti, A, Miniati, M, Lattanzi, L, Mantua, V, Lombardi, V, Fagiolini, A, Frank, E

“…Abstract Background The recognition and assessment of psychomotor retardation may have implications for better definition of the clinical phenotypes of…”
Get full text

P-776 - Protein biomarkers in psychotic patients by Mantua, V, Giusti, L, Orsolini, G, Ventroni, T, Mauri, M, Lucacchini, A

“…Introduction Psychotic disorders such as schizophrenia and bipolar disorder are complex neuropsychiatric conditions of multifactorial etiology whose diagnosis…”
Get full text

P.2.a.043 Psychoticism dimension in a population of patients with non-psychotic major depression disorder by Mantua, V, Calugi, S, Schiavi, E, Miniati, M, Cassano, G.B

Get full text

P.3.c.068 Olanzapine orodispersible vs haloperidol both associated with lorazepam in the treatment of agitation by Mantua, V, Travis, M.J, Atakan, Z, Isaac, M.B, Issac, M.T, Sweeney, C, Komeh, J, Shaw, A, Rucci, P, Kerwin, R.W

Get full text

Clinical trials and late‐stage drug development for A lzheimer's disease: an appraisal from 1984 to 2014 by Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., Kivipelto, M.

“…Abstract The modern era of drug development for A lzheimer's disease began with the proposal of the cholinergic hypothesis of memory impairment and the 1984…”
Get full text

Sex differences in Alzheimer's disease: current challenges and implications for clinical research by Ferretti, MT, Martinkova, J, Biskup, E, Benke, T, Gialdini, G, Nedelska, Z, Rauen, K, Mantua, V, Religa, D, Hort, J, Chadha, AS, Schmidt, R

Get full text

Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease by Bradley, Patrick, Akehurst, Ron, Ballard, Clive, Banerjee, Sube, Blennow, Kaj, Bremner, Jennifer, Broich, Karl, Cummings, Jeffrey, Dening, Karen, Dubois, Bruno, Klipper, Wiebke, Leibman, Chris, Mantua, Valentina, Molinuevo, José Luis, Morgan, Susan, Muscolo, Luisa A.A, Nicolas, François, Pani, Luca, Robinson, Louise, Siviero, Paolo, van Dam, Julius, Van Emelen, Jan, Wimo, Anders, Wortmann, Marc, Goh, Lindee

“…Abstract Health-care stakeholders increasingly recognize that the scientific and economic challenges associated with Alzheimer's disease (AD) are simply too…”
Get full text

P.3.08 Effect of different neurochemicals on peripheral BDNF production by Mantua, V., Myint, A.-M., Kubera, M., Maes, M.

Get full text

P.3.c.045 Treatment of agitation caused by severe mental illness: data from the South London and Maudsley intensive care units trial evaluation (SLAMICUTE) study by Mantua, V., Travis, M.J., Atakan, Z., Isaac, M.B., Isaac, M.T., Smith, S., Gilbert, D., Komeh, J., Shaw, A., Sweeney, C., Kerwin, R.W.

Get full text